+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Can-Fite BioPharma Ltd (CANF) - Financial and Strategic SWOT Analysis Review

  • ID: 4284875
  • SWOT Analysis
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that offers pharmaceutical discovery and clinical development services. The company's pipeline product portfolio includes CF101, CF102 and CF602. It develops its products by utilizing its platform technology based on the Gi protein coupled A3 adenosine receptor (A3AR) in inflammatory and cancer cells. Can-Fite developes drugs that are used in the treatment of various diseases such as cancer, sexual dysfunction, inflammatory diseases and ophthalmic indications. The company’s CF 102, is an oral drug used to treat liver cancer and CF 602, is an allosteric modulator used in the treatment of inflammatory diseases. It conducts Phase I, II and III clinical trials for various indications across the US and Israel. Can-Fite is headquartered in Petah-Tikva, Israel.

Can-Fite BioPharma Ltd Key Recent Developments

Jan 11, 2018: Can-Fite 12 Months' Activities & Milestones for 2018
Nov 27, 2017: Can-Fite Reports Third Quarter 2017 Financial Results & Provides Clinical Update
Sep 18, 2017: Can-Fite Files Patent Application to Treat Cytokine Release Syndrome, a Potentially Life-Threatening Complication of CAR-T Cell Therapy
Sep 01, 2017: Can-Fite Reports Second Quarter 2017 Financial Results & Provides Clinical Update
Jun 05, 2017: Can-Fite BioPharma establishes clinical advisory board for NAFLD and NASH treatment

This comprehensive SWOT profile of Can-Fite BioPharma Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Can-Fite BioPharma Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Can-Fite BioPharma Ltd - Key Information
  • Can-Fite BioPharma Ltd - Overview
  • Can-Fite BioPharma Ltd - Key Employees
  • Can-Fite BioPharma Ltd - Key Employee Biographies
  • Can-Fite BioPharma Ltd - Key Operational Heads
  • Can-Fite BioPharma Ltd - Major Products and Services
  • Can-Fite BioPharma Ltd - History
  • Can-Fite BioPharma Ltd - Company Statement
  • Can-Fite BioPharma Ltd - Locations And Subsidiaries
  • Can-Fite BioPharma Ltd - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Can-Fite BioPharma Ltd - Business Description
  • Can-Fite BioPharma Ltd - Corporate Strategy
  • Can-Fite BioPharma Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Can-Fite BioPharma Ltd - Strengths
  • Can-Fite BioPharma Ltd - Weaknesses
  • Can-Fite BioPharma Ltd - Opportunities
  • Can-Fite BioPharma Ltd - Threats
  • Can-Fite BioPharma Ltd - Key Competitors
Section 3 - Company Financial Performance Charts
  • Can-Fite BioPharma Ltd - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Can-Fite BioPharma Ltd, Key Information
  • Can-Fite BioPharma Ltd, Key Ratios
  • Can-Fite BioPharma Ltd, Share Data
  • Can-Fite BioPharma Ltd, Major Products and Services
  • Can-Fite BioPharma Ltd, History
  • Can-Fite BioPharma Ltd, Key Employees
  • Can-Fite BioPharma Ltd, Key Employee Biographies
  • Can-Fite BioPharma Ltd, Key Operational Heads
  • Can-Fite BioPharma Ltd, Other Locations
  • Can-Fite BioPharma Ltd, Subsidiaries
  • Can-Fite BioPharma Ltd, Key Manufacturing facilities
  • Can-Fite BioPharma Ltd, Key Competitors
  • Can-Fite BioPharma Ltd, SWOT Analysis
  • Can-Fite BioPharma Ltd, Ratios based on current share price
  • Can-Fite BioPharma Ltd, Annual Ratios
  • Can-Fite BioPharma Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Can-Fite BioPharma Ltd, Performance Chart
  • Can-Fite BioPharma Ltd, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3